goserelin and altrenogest

The generic GnRH agonist, Fertilan (goserelin), was tested for the ability to induce an LH surge and ovulation in estrus-synchronized gilts. Three experiments were performed to 1) examine the effect of various doses of Fertilan on secretion of LH in barrows, to select doses to investigate in gilts (Exp. 1); 2) determine doses of Fertilan that would induce a preovulatory-like rise of LH in gilts (Exp. 2); and 3) determine the time of ovulation after Fertilan treatment (Exp. 3). In Exp. 1, 10 barrows were injected on d 1, 4, 7, 10, and 13 with 10, 20, or 40 microg of Fertilan; 50 microg of Gonavet (depherelin; GnRH control) or saline (negative control); and sequential blood samples were collected for 480 min. There was a dose-dependent stimulation (P < 0.05) of LH release. Maximal plasma concentrations of LH (LH(MAX)) were 2.1 +/- 0.2, 4.1 +/- 0.3, 2.6 +/- 0.4, and 3.4 +/- 0.3 ng/mL after 10, 20, and 40 microg of Fertilan and 50 microg of Gonavet, respectively, and duration of release was 78 +/- 9, 177 +/- 12, 138 +/- 7, and 180 +/- 11 min, respectively. Fertilan doses of 10 and 20 microg were deemed to be the most suitable for testing in gilts. In Exp. 2, 12 gilts received (after estrus synchronization with Regumate and eCG) injections of 10 or 20 microg of Fertilan or 50 microg of Gonavet 80 h after eCG to stimulate a preovulatory-like LH surge and ovulation. An LH surge was induced in 3 of the 4 gilts in both of the Fertilan groups and in all of the Gonavet-treated gilts. Characteristics of induced release of LH did not differ among groups: LH(MAX), 5.0 +/- 0.9 vs. 4.6 +/- 1.8 vs. 6.6 +/- 1.1 ng/mL; duration, 11.7 +/- 2.0 vs. 12.3 +/- 2.2 vs. 14.3 +/- 0.5 h; interval from GnRH injection to LH(MAX), 4.0 +/- 2.0 vs. 6.7 +/- 1.3 vs. 5.8 +/- 1.6 h. In Exp. 3, estrus-synchronized gilts were injected with 20 microg of Fertilan (n = 8) or 50 microg of Gonavet (n = 4), and the time of ovulation was determined by repeated endoscopic examination. Time of ovulation ranged from 34 to 42 h postGnRH; however, ovulation occurred earlier in the Gonavet compared with the other groups (P < 0.05). Results of these experiments indicate that 1) barrows are an appropriate model for determining GnRH doses that can be effective in inducing a preovulatory-like LH surge in females; 2) the generic GnRH agonist Fertilan, at doses of 10 to 20 microg, can stimulate an LH surge in gilts, with subsequent ovulation; and 3) Fertilan at doses of 10 and 20 microg should be examined further

Topics: Animals; Chorionic Gonadotropin; Estrus Synchronization; Female; Gonadotropin-Releasing Hormone; Goserelin; Luteinizing Hormone; Male; Ovulation Induction; Swine; Trenbolone Acetate

A total of 18 experimental pony and 136 commercial maiden, barren and foaling Thoroughbred mares in seasonal or lactation-related anoestrus were injected subcutaneously with 1 or 2 slow-release D,L-lactide-glycolide co-polymer implants impregnated with 0.9 or 1.8 mg of the potent GnRH analogue, ICI 118 630, to give a daily release of, respectively, 30 or 60 micrograms analogue for 28 days; 32 of the Thoroughbred mares were also given a daily oral dose of 27.5 mg allyl trenbolone for 5 days after injection of the implant. Thirteen pony (76%) and 120 Thoroughbred (88%) mares ovulated 3-18 days after treatment with ICI 118 630 and the additional treatment with allyl trenbolone did not significantly reduce the considerable variation in the interval between treatment with GnRH analogue and ovulation. Of 100 Thoroughbred mares mated during the GnRH analogue-induced oestrus, (70%) conceived. The results of this trial demonstrated that low-dose, slow-release formulations of GnRH agonists have considerable potential as a practical method of hastening renewed ovarian cyclicity in anoestrous mares.

Topics: Anestrus; Animals; Buserelin; Drug Implants; Estrus; Female; Goserelin; Horses; Ovulation Induction; Progesterone Congeners; Trenbolone Acetate